Safety, Tolerability and PK of Single and Multiple Doses of Oxantel Pamoate Tablets

NCT06606860 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Healthy

Interventions

DRUG: Oxantel Pamoate
DRUG: Placebo

Sponsor

Swiss Tropical & Public Health Institute

Collaborators

[object Object]
[object Object]